Form 4: Neuronetics Director Glenn Muir Increases Stake in Company
SEC Form 4 Filing
Director Glenn Muir purchased 44,444 shares of Neuronetics (STIM) common stock at $2.25 per share on February 7, 2025, increasing his total holdings.
Summary
- On February 7, 2025, Glenn Muir, a director of Neuronetics, Inc. (STIM), acquired 44,444 shares of common stock.
- The purchase price was $2.25 per share.
- This transaction increased Muir's direct holdings to 334,262 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Purchases by insiders are often viewed positively by the market.
Stakeholder Impact
- The increased stake of a director could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of stock purchase transaction |
| 02/10/2025 | Date of signature on the Form 4 filing |
Keywords
Neuronetics, STIM, Glenn Muir, stock purchase, director, Form 4, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.